Decoy Therapeutics
Cambridge
About Decoy Therapeutics
Decoy Therapeutics is a preclinical stage biotech company building a pandemic preparedness drug development platform using AI design of peptide ‘decoys’ that directly interfere with viral replication machinery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Funding stage: M&A
- Last round: Convertible Note (Apr 2021)
- Website: decoytx.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/decoy-therapeutics-79032 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.